Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral Solution

DoP upholds NPPA ceiling price fixation for Azoran 50mg tablet

Farhat Nasim5 Nov 2024 6:10 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has upheld the ceiling price for Azathioprine 50mg tablets, as determined by the National...

Chemist Body up against Swiggy-PharmEasy's 10-Minute Medicine Delivery Model, Seeks DCGI Intervention

Farhat Nasim5 Nov 2024 4:04 PM IST

New Delhi: The All India Organization of Chemists and Druggists (AIOCD) has voiced strong objections to a potential partnership between Swiggy...

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

Sun Pharma alopecia drug Leqselvi launch blocked in US

Farhat Nasim4 Nov 2024 7:05 PM IST

New Delhi: Pharma giant, Sun Pharmaceutical's launch of its specialty drug Leqselvi in the U.S. market is in limbo as the U.S. District Court in...

AYUSH Simplifies Licensing for Drug Manufacturers with New Fee Structure, Details

Farhat Nasim4 Nov 2024 7:03 PM IST

New Delhi: The Ministry of AYUSH has amended the Drugs Rules of 1945 to streamline the licensing process for Ayurveda, Siddha, Sowa-Rigpa, Unani, and...

CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR Data

DoP rejects Glenmark's appeal on price cap of Clotrimazole Cream

Farhat Nasim3 Nov 2024 12:45 PM IST

New Delhi: The Department of Pharmaceuticals has upheld the National Pharmaceutical Pricing Authority's (NPPA) decision on the price cap for...

Pfizer Wysolone DT price challenge denied: DoP upholds NPPA ceiling on Prednisolone Tablets

Farhat Nasim2 Nov 2024 1:00 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has upheld a price ceiling order issued by the National Pharmaceutical Pricing Authority (NPPA) on...

CDSCO Panel Rejects Troikaa Pharmas High-Strength Paracetamol Injection Citing Safety Concerns

La Renon's plea to exempt Sodium Valproate from NPPA price cap rejected

Farhat Nasim31 Oct 2024 2:00 PM IST

New Delhi: The Department of Pharmaceuticals (DoP), functional under India's Ministry of Chemicals and Fertilizers, has rejected an appeal from La...

Cipla to buy 100 percent stake in Inzpera Healthsciences for Rs 110.65 crores

DoP orders NPPA to reassess price of Cipla's Advent, Synclar and Azee drugs

Farhat Nasim30 Oct 2024 6:14 PM IST

New Delhi: The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals & Fertilizers, has issued orders to the National...

Severe risk with import of second hand CT scanners, MRI machines, surgical robots, warns industry body, files PIL

Farhat Nasim27 Oct 2024 12:30 PM IST

New Delhi: Medical device manufacturers in India are sounding alarms over the unregulated import of refurbished medical devices, emphasizing serious...

Novartis concludes acquisition of Tourmaline Bio

Novartis' Ribociclib named as Category 1 Preferred Adjuvant Treatment for Breast Cancer in NCCN Guidelines

Farhat Nasim27 Oct 2024 10:15 AM IST

Basel: This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib...

Dexcom Beats Quarterly Sales Expectations, Reaffirms Annual Outlook

MD Bureau27 Oct 2024 10:00 AM IST

Analysts had raised concerns about the pace at which Dexcom was capturing "basal only" diabetes patients who take one insulin injection a day

West Pharmas 2025 Forecast Misses Estimates as Inventory Reductions Continue

West Pharma Raises 2024 Profit Forecast Amid Surging Demand for Injectable Therapy Supplies

MD Bureau27 Oct 2024 9:45 AM IST

Bengaluru: West Pharmaceutical Services raised its annual profit outlook on Thursday after exceeding Wall Street's expectations for quarterly...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok